Atlas Trials

A Study to Evaluate the Safety and Efficacy of Itacitinib in Moderate to Severe Ulcerative Colitis

Clinical trial NCT03627052 · WITHDRAWN

Trial details

NCT number
NCT03627052
Sponsor
Incyte Corporation
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Moderate to Severe Ulcerative Colitis
Start date
2018-09-20
Primary completion
2019-11-13
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.